Free shipping on all orders over $ 500

 About 1 result found for searched term "Canlitinib" (0.201 seconds)

Cat.No.  Name Target
M43488 Canlitinib c-Met
Canlitinib is a tyrosine kinase inhibitor, extracted from patent WO2018072614 (IV-2).


 
Get to Know Us
Customer Support
Resources
Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.